These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6833435)

  • 21. Strain differences of antipyrine, trimethadione, and debrisoquine metabolism in female rats.
    Tanaka E; Kobayashi S; Yasuhara H; Misawa S
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):233-6. PubMed ID: 2396050
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of selective cytochrome P-450 inducing agents on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in rats.
    Tanaka E; Etoh H; Misawa S
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):375-8. PubMed ID: 2385760
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between trimethadione metabolism and hepatic drug-oxidizing enzyme activities in different animal species.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    J Pharmacobiodyn; 1983 Jul; 6(7):481-6. PubMed ID: 6644533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of the demethylation of trimethadione to dimethadione.
    Frey HH; Schulz R
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):325-6. PubMed ID: 4253766
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
    Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
    J Pharmacobiodyn; 1987 Sep; 10(9):499-502. PubMed ID: 2830397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simplified test for determination of drug-oxidizing capacity in rats with chemical-induced liver injury using caffeine and trimethadione as model drugs.
    Tanaka E; Ishikawa A; Misawa S
    Pharmacol Toxicol; 1992 Mar; 70(3):177-80. PubMed ID: 1579543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic trimethadione-oxidizing capacity remains normal in patients with extrahepatic cholelithiasis.
    Tanaka E; Ishikawa A; Ono A; Takada A; Okamura T; Misawa S
    J Pharmacobiodyn; 1986 May; 9(5):506-9. PubMed ID: 3761137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of famotidine and cimetidine on trimethadione metabolism in the rat.
    Tanaka E; Misawa S; Kuroiwa Y
    Biochem Pharmacol; 1986 Mar; 35(5):869-71. PubMed ID: 2869758
    [No Abstract]   [Full Text] [Related]  

  • 29. Simultaneous determination of dimethadione and trimethadione by infrared-spectrometry: application for mean intracellular pH measurement.
    Zweens J; Frankena H
    J Clin Chem Clin Biochem; 1984 Oct; 22(10):641-5. PubMed ID: 6512494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of trimethadione and its metabolite, dimethadione, by gas-liquid chromatography.
    Booker HE; Darcey B
    Clin Chem; 1971 Jul; 17(7):607-9. PubMed ID: 5556887
    [No Abstract]   [Full Text] [Related]  

  • 31. Trimethadione tolerance test for the quantitative assessment of liver function in rats.
    Ishikawa A; Fukao K; Tanaka E; Tsuji K; Osada A; Yamamoto Y; Kiyosawa T; Iwasaki Y
    J Gastroenterol Hepatol; 1991; 6(4):363-7. PubMed ID: 1912445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.
    Tanaka E; Ishikawa A; Kobayashi S; Yasuhara H; Misawa S; Kuroiwa Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Feb; 104(2):205-7. PubMed ID: 8098675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratogenic effects of trimethadione and dimethadione in the chich embryo.
    Rifkind AB
    Toxicol Appl Pharmacol; 1974 Dec; 30(3):452-7. PubMed ID: 4446037
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenytoin and trimethadione: pharmacokinetics, embryotoxicity, and maternal toxicity.
    Khera KS
    Prog Clin Biol Res; 1985; 163C():317-22. PubMed ID: 3991637
    [No Abstract]   [Full Text] [Related]  

  • 35. Age-related changes in trimethadione oxidizing capacity.
    Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
    Br J Clin Pharmacol; 1987 Mar; 23(3):355-7. PubMed ID: 3567052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of organic solvents on trimethadione n-demethylation in rats.
    Nishimura Y; Kurata N; Iwase M; Li H; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):229-39. PubMed ID: 10634315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs.
    Noda A; Okumura I; Kato H; Ibuki E; Tamada M; Watanabe T
    Digestion; 1990; 46(1):19-26. PubMed ID: 2210093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-variation in frequency and severity of cardiovascular and skeletal defects in Sprague-Dawley rats after maternal administration of dimethadione, the N-demethylated metabolite of trimethadione.
    Weston AD; Brown NA; Ozolinš TR
    Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):206-15. PubMed ID: 21638752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione.
    Alderdice MT; McMillan JE
    J Pharmacol Exp Ther; 1982 Jun; 221(3):547-51. PubMed ID: 6283057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.